郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价New quinoxaline derivatives as potential MT₁ and MT₂ receptor ligands.

期刊：Molecules (Basel, Switzerland)发表年份：2012作者：Saioa Ancizu; Nerea Castrillo; Silvia Pérez-Silanes; Ignacio Aldana; Antonio Monge; Philippe Delagrange; Daniel-Henry Caignard; Silvia Galiano
阅读更多 →

药效评价Fragment screening of GPCRs using biophysical methods: identification of ligands of the adenosine A(2A) receptor with novel biological activity.

期刊：ACS chemical biology发表年份：2012作者：Dan Chen; James C Errey; Laura H Heitman; Fiona H Marshall; Adriaan P Ijzerman; Gregg Siegal
阅读更多 →

药效评价GPR35 is a target of the loop diuretic drugs bumetanide and furosemide.

期刊：Pharmacology发表年份：2012作者：Yuhua Yang; Angela Fu; Xiaosu Wu; Jeff D Reagan
阅读更多 →

药效评价In search for new chemical entities as adenosine receptor ligands: development of agents based on benzo-γ-pyrone skeleton.

期刊：European journal of medicinal chemistry发表年份：2012作者：Alexandra Gaspar; Joana Reis; Maria João Matos; Eugenio Uriarte; Fernanda Borges
阅读更多 →